Draeger hires new business development manager

Nathan Sanicharane takes up the role

Draeger hires new business development manager

Nathan Sanicharane has been appointed as new business development manager for the chemicals sector at safety equipment specialist Draeger Safety UK.

Sanicharane has a Masters degree in Chemistry and has spent four years working in drugs development. He also has nearly five years’ experience in selling chromatography and specialist chemicals.

You may also like

Regulatory
Measurement uncertainty explained – Why it matters more than you think

Measurement uncertainty explained – Why it matters more than you think

In regulated environments, where decisions often depend on whether a result passes or fails a defined limit, understanding measurement uncertainty becomes critical
Regulatory
Sanofi expands vaccine manufacturing in Abu Dhabi as NICE backs its diabetes therapy

Sanofi expands vaccine manufacturing in Abu Dhabi as NICE backs its diabetes therapy

Sanofi advances on two fronts: a new Abu Dhabi vaccine innovation centre with AI and mRNA capabilities and UK NICE backing for teplizumab, the first disease-modifying treatment for type 1 diabetes
Manufacturing
RFID brings greater visibility to pharmaceutical supply chains

RFID brings greater visibility to pharmaceutical supply chains

From hospital pharmacies to global distribution networks, RFID is adding a new layer of intelligence to pharmaceutical logistics
Manufacturing
Cogent Skills research exposes specialist skills gaps holding back UK medicines manufacturing SMEs

Cogent Skills research exposes specialist skills gaps holding back UK medicines manufacturing SMEs

The Office for Life Sciences-funded report identifies acute gaps in commercial, R&D and digital competencies, recommending simplified apprenticeships and GMP-ready micro-credentials to support sector growth
Regulatory
Pharmaceutical regulatory update 2026: EU, UK, FDA & global changes explained

Pharmaceutical regulatory update 2026: EU, UK, FDA & global changes explained

EU Pharma Legislation overhaul + Global GMP updates (2026)
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
What Operation TrialBlazer means for CDMOs and CMC strategy

What Operation TrialBlazer means for CDMOs and CMC strategy

The FDA's new framework cuts Phase I data requirements, opens platform manufacturing data reuse and creates a new CRO/CDMO review role as HHS moves to close the gap with China's faster clinical trial pipeline — but how will this affect the pharma sector?
Manufacturing
Piramal Pharma Solutions highlights strong performance across more than 200 customer audits

Piramal Pharma Solutions highlights strong performance across more than 200 customer audits

Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes
Subscribe now